Cargando…

Development and validation of a simple-to-use nomogram to predict the deterioration and survival of patients with COVID-19

BACKGROUND: COVID-19 pandemic has forced physicians to quickly determine the patient’s condition and choose treatment strategies. This study aimed to build and validate a simple tool that can quickly predict the deterioration and survival of COVID-19 patients. METHODS: A total of 351 COVID-19 patien...

Descripción completa

Detalles Bibliográficos
Autores principales: Zeng, Zhiyong, Wu, Chaohui, Lin, Zhenlv, Ye, Yong, Feng, Shaodan, Fang, Yingying, Huang, Yanmei, Li, Minhua, Du, Debing, Chen, Gongping, Kang, Dezhi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8050645/
https://www.ncbi.nlm.nih.gov/pubmed/33863287
http://dx.doi.org/10.1186/s12879-021-06065-z
_version_ 1783679620780916736
author Zeng, Zhiyong
Wu, Chaohui
Lin, Zhenlv
Ye, Yong
Feng, Shaodan
Fang, Yingying
Huang, Yanmei
Li, Minhua
Du, Debing
Chen, Gongping
Kang, Dezhi
author_facet Zeng, Zhiyong
Wu, Chaohui
Lin, Zhenlv
Ye, Yong
Feng, Shaodan
Fang, Yingying
Huang, Yanmei
Li, Minhua
Du, Debing
Chen, Gongping
Kang, Dezhi
author_sort Zeng, Zhiyong
collection PubMed
description BACKGROUND: COVID-19 pandemic has forced physicians to quickly determine the patient’s condition and choose treatment strategies. This study aimed to build and validate a simple tool that can quickly predict the deterioration and survival of COVID-19 patients. METHODS: A total of 351 COVID-19 patients admitted to the Third People’s Hospital of Yichang between 9 January to 25 March 2020 were retrospectively analyzed. Patients were randomly grouped into training (n = 246) or a validation (n = 105) dataset. Risk factors associated with deterioration were identified using univariate logistic regression and least absolute shrinkage and selection operator (LASSO) regression. The factors were then incorporated into the nomogram. Kaplan-Meier analysis was used to compare the survival of patients between the low- and high-risk groups divided by the cut-off point. RESULTS: The least absolute shrinkage and selection operator (LASSO) regression was used to construct the nomogram via four parameters (white blood cells, C-reactive protein, lymphocyte≥0.8 × 10(9)/L, and lactate dehydrogenase ≥400 U/L). The nomogram showed good discriminative performance with the area under the receiver operating characteristic (AUROC) of 0.945 (95% confidence interval: 0.91–0.98), and good calibration (P = 0.539). Besides, the nomogram showed good discrimination performance and good calibration in the validation and total cohorts (AUROC = 0.979 and AUROC = 0.954, respectively). Decision curve analysis demonstrated that the model had clinical application value. Kaplan-Meier analysis illustrated that low-risk patients had a significantly higher 8-week survival rate than those in the high-risk group (100% vs 71.41% and P < 0.0001). CONCLUSION: A simple-to-use nomogram with excellent performance in predicting deterioration risk and survival of COVID-19 patients was developed and validated. However, it is necessary to verify this nomogram using a large-scale multicenter study. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12879-021-06065-z.
format Online
Article
Text
id pubmed-8050645
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-80506452021-04-16 Development and validation of a simple-to-use nomogram to predict the deterioration and survival of patients with COVID-19 Zeng, Zhiyong Wu, Chaohui Lin, Zhenlv Ye, Yong Feng, Shaodan Fang, Yingying Huang, Yanmei Li, Minhua Du, Debing Chen, Gongping Kang, Dezhi BMC Infect Dis Research BACKGROUND: COVID-19 pandemic has forced physicians to quickly determine the patient’s condition and choose treatment strategies. This study aimed to build and validate a simple tool that can quickly predict the deterioration and survival of COVID-19 patients. METHODS: A total of 351 COVID-19 patients admitted to the Third People’s Hospital of Yichang between 9 January to 25 March 2020 were retrospectively analyzed. Patients were randomly grouped into training (n = 246) or a validation (n = 105) dataset. Risk factors associated with deterioration were identified using univariate logistic regression and least absolute shrinkage and selection operator (LASSO) regression. The factors were then incorporated into the nomogram. Kaplan-Meier analysis was used to compare the survival of patients between the low- and high-risk groups divided by the cut-off point. RESULTS: The least absolute shrinkage and selection operator (LASSO) regression was used to construct the nomogram via four parameters (white blood cells, C-reactive protein, lymphocyte≥0.8 × 10(9)/L, and lactate dehydrogenase ≥400 U/L). The nomogram showed good discriminative performance with the area under the receiver operating characteristic (AUROC) of 0.945 (95% confidence interval: 0.91–0.98), and good calibration (P = 0.539). Besides, the nomogram showed good discrimination performance and good calibration in the validation and total cohorts (AUROC = 0.979 and AUROC = 0.954, respectively). Decision curve analysis demonstrated that the model had clinical application value. Kaplan-Meier analysis illustrated that low-risk patients had a significantly higher 8-week survival rate than those in the high-risk group (100% vs 71.41% and P < 0.0001). CONCLUSION: A simple-to-use nomogram with excellent performance in predicting deterioration risk and survival of COVID-19 patients was developed and validated. However, it is necessary to verify this nomogram using a large-scale multicenter study. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12879-021-06065-z. BioMed Central 2021-04-16 /pmc/articles/PMC8050645/ /pubmed/33863287 http://dx.doi.org/10.1186/s12879-021-06065-z Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Zeng, Zhiyong
Wu, Chaohui
Lin, Zhenlv
Ye, Yong
Feng, Shaodan
Fang, Yingying
Huang, Yanmei
Li, Minhua
Du, Debing
Chen, Gongping
Kang, Dezhi
Development and validation of a simple-to-use nomogram to predict the deterioration and survival of patients with COVID-19
title Development and validation of a simple-to-use nomogram to predict the deterioration and survival of patients with COVID-19
title_full Development and validation of a simple-to-use nomogram to predict the deterioration and survival of patients with COVID-19
title_fullStr Development and validation of a simple-to-use nomogram to predict the deterioration and survival of patients with COVID-19
title_full_unstemmed Development and validation of a simple-to-use nomogram to predict the deterioration and survival of patients with COVID-19
title_short Development and validation of a simple-to-use nomogram to predict the deterioration and survival of patients with COVID-19
title_sort development and validation of a simple-to-use nomogram to predict the deterioration and survival of patients with covid-19
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8050645/
https://www.ncbi.nlm.nih.gov/pubmed/33863287
http://dx.doi.org/10.1186/s12879-021-06065-z
work_keys_str_mv AT zengzhiyong developmentandvalidationofasimpletousenomogramtopredictthedeteriorationandsurvivalofpatientswithcovid19
AT wuchaohui developmentandvalidationofasimpletousenomogramtopredictthedeteriorationandsurvivalofpatientswithcovid19
AT linzhenlv developmentandvalidationofasimpletousenomogramtopredictthedeteriorationandsurvivalofpatientswithcovid19
AT yeyong developmentandvalidationofasimpletousenomogramtopredictthedeteriorationandsurvivalofpatientswithcovid19
AT fengshaodan developmentandvalidationofasimpletousenomogramtopredictthedeteriorationandsurvivalofpatientswithcovid19
AT fangyingying developmentandvalidationofasimpletousenomogramtopredictthedeteriorationandsurvivalofpatientswithcovid19
AT huangyanmei developmentandvalidationofasimpletousenomogramtopredictthedeteriorationandsurvivalofpatientswithcovid19
AT liminhua developmentandvalidationofasimpletousenomogramtopredictthedeteriorationandsurvivalofpatientswithcovid19
AT dudebing developmentandvalidationofasimpletousenomogramtopredictthedeteriorationandsurvivalofpatientswithcovid19
AT chengongping developmentandvalidationofasimpletousenomogramtopredictthedeteriorationandsurvivalofpatientswithcovid19
AT kangdezhi developmentandvalidationofasimpletousenomogramtopredictthedeteriorationandsurvivalofpatientswithcovid19